HomeHAE • NYSE
Haemonetics Corporation
$85.55
After Hours:
$85.55
(0.00%)0.00
Closed: Nov 22, 4:08:36 PM GMT-5 · USD · NYSE · Disclaimer
StockUS listed securityUS headquartered
Previous close
$85.43
Day range
$84.50 - $86.00
Year range
$70.25 - $97.97
Market cap
4.30B USD
Avg Volume
661.35K
P/E ratio
35.53
Dividend yield
-
Primary exchange
NYSE
Market news
Financials
Income Statement
Revenue
Net income
(USD)Sep 2024Y/Y change
Revenue
345.51M8.59%
Operating expense
134.39M3.59%
Net income
33.83M35.82%
Net profit margin
9.7925.03%
Earnings per share
1.1213.13%
EBITDA
86.03M34.43%
Effective tax rate
24.32%
Total assets
Total liabilities
(USD)Sep 2024Y/Y change
Cash and short-term investments
300.03M-15.15%
Total assets
2.53B25.55%
Total liabilities
1.65B47.31%
Total equity
878.85M
Shares outstanding
50.22M
Price to book
4.90
Return on assets
5.61%
Return on capital
6.46%
Net change in cash
(USD)Sep 2024Y/Y change
Net income
33.83M35.82%
Cash from operations
48.82M-50.75%
Cash from investing
-23.37M7.03%
Cash from financing
-74.80M-943.00%
Net change in cash
-45.15M-169.15%
Free cash flow
38.56M-24.46%
About
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen Latham in the 1970s. Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas. Wikipedia
Founded
1971
Employees
3,657
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu